menu search

In8bio to present new positive data from phase 1 trial of inb-100 at 2023 american society of hematology (ash) annual meeting

NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta ...

November 2, 2023, 9:17 am

Corvus pharmaceuticals to present new interim soquelitinib data from its phase 1/1b t cell lymphoma trial at the 65th american society of hematology (ash) annual meeting & exposition

BURLINGAME, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today ...

November 2, 2023, 9:15 am

After a year colt seals the $1.8b purchase of lumen emea

Colt, a service provider for numerous retail brokers, financial firms, and crypto exchanges, announced today (Thursday) that it has acquired Lumen EME...

November 2, 2023, 9:14 am

Vincerx pharma to present three posters at ash 2023 in december

VIP943 poster supports selectivity and safety of lead CD123 ADC, VIP943, currently in Phase 1 VIP924 poster shows this novel CXCR5-ADC compares favora...

November 2, 2023, 9:10 am

Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato

BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today announced that new data from an additional 52-w...

November 2, 2023, 9:09 am

Centessa pharmaceuticals to present additional 52-weeks of continuous treatment data from third year of ongoing phase 2a study of serpinpc for the treatment of hemophilia at american society of hemato

BOSTON and LONDON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA) today announced that new data from an additional 52-w...

November 2, 2023, 9:09 am

Ingevity's (ngvt) earnings and sales miss estimates in q3

Lower volumes due to weak industrial demand hurt Ingevity's (NGVT) Advanced Polymer Technologies and th...

November 2, 2023, 9:01 am

Ingersoll rand (ir) q3 earnings rise 24.2% y/y, '23 view up

Ingersoll Rand's (IR) Q3 results benefit from higher revenues of the Industrial Technologies segment. T...

November 2, 2023, 9:01 am

Cematrix to report third quarter results on november 8, 2023 earnings webinar scheduled for 1:00 p.m. et, november 9, 2023

CALGARY, Alberta, Nov. 02, 2023 (GLOBE NEWSWIRE) -- CEMATRIX Corporation (TSXV: CVX) (OTCQB: CTXXF) ("CEMATRIX" or the "Company") a North American lea...

November 2, 2023, 8:30 am

Predictmedix ai to showcase impairment screening technology at 30-country summit in india

Predictmedix AI Inc. (CSE:PMED, OTCQB:PMEDF) told investors it has been invited to showcase its innovative impairment screening techn...

November 2, 2023, 8:26 am

Phunware to wind down lyte technology operations to reinforce core mission

Phunware Inc (NASDAQ:PHUN) has announced it is winding down the operations of its gaming PC manufacturer subsidiary Lyte Techn...

November 2, 2023, 8:06 am

Recursion to participate in upcoming investor conference

SALT LAKE CITY, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding bi...

November 2, 2023, 8:05 am

Roper technologies: i stay bullish

Roper Technologies has strong Q3 results, with steady organic sales growth and strong free cash flow. T...

November 2, 2023, 7:39 am

Should you invest in the invesco semiconductors etf (psi)?

If you're interested in broad exposure to the Technology - Semiconductors segment of the equity market,...

November 2, 2023, 7:31 am

Palantir earnings show ai traction, while company hits a milestone on profits

Palantir Technologies Inc. just notched its fourth quarterly GAAP profit in a row, and executives at th...

November 2, 2023, 7:01 am

Kalvista pharmaceuticals to present data at the 2023 annual scientific meeting of the american college of allergy, asthma & immunology

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)---- $KALV--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical compa...

November 2, 2023, 6:30 am

Roadkill alert: why goog stock is about to get run over

For now, Google and YouTube parent company Alphabet (NASDAQ: GOOG , NASDAQ: GOOGL ) has a dominant position in the search-engine market. However, now...

November 2, 2023, 6:25 am

Why venture capital is a better ai play than large-cap equities

Sceptics cautious about the hype surrounding artificial intelligence underestimate the major scientific and civilisational advancements the techn...

November 2, 2023, 4:44 am

Rlx technology to report third quarter 2023 financial results on november 13, 2023

- Earnings Call Scheduled for 7:00 a.m. ET on November 13, 2023 – BEIJING , Nov. 2, 2023 /PRNewswire/ -- RLX Techn...

November 2, 2023, 3:00 am

Molecular partners to present initial data from ongoing phase 1/2a trial of mp0533 for patients with relapsed/refractory aml and aml/mds at the 65th ash annual meeting and exposition

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG (...

November 2, 2023, 2:00 am


Search within

Pages Search Results: